US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.100
- -0.360-24.66%
Close Sep 3 16:00 ET
- 1.090
- -0.010-0.91%
Post 20:02 ET
8.58MMarket Cap-632P/E (TTM)
1.435High1.000Low725.49KVolume1.420Open1.460Pre Close823.91KTurnover39.00%Turnover RatioLossP/E (Static)7.80MShares13.55852wk High-1.70P/B2.05MFloat Cap1.00052wk Low--Dividend TTM1.86MShs Float13.558Historical High--Div YieldTTM29.80%Amplitude1.000Historical Low1.135Avg Price1Lot Size
Silexion Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||
| Cash flow from continuing operating activities | 36.46%-1.07M | -92.32%-1.75M | -35.80%-4.53M | -1.68M | -911K | -3.34M |
| Net income from continuing operations | 20.63%-1.49M | -91.52%-1.42M | -46.44%-5.11M | ---1.88M | ---743K | ---3.49M |
| Operating gains losses | ---- | ---- | ---1K | ---- | ---- | ---- |
| Depreciation and amortization | -50.00%7K | -46.67%8K | -21.05%45K | --14K | --15K | --57K |
| Other non cash items | -70.14%83K | 747.62%136K | 218.66%318K | --278K | ---21K | ---268K |
| Change In working capital | 343.55%302K | -160.31%-505K | -63.60%87K | ---124K | ---194K | --239K |
| -Change in receivables | 110.00%2K | -500.00%-44K | 145.00%18K | ---20K | --11K | ---40K |
| -Change in prepaid assets | -1,360.00%-63K | -1,742.86%-129K | -179.28%-329K | --5K | ---7K | --415K |
| -Change in payables and accrued expense | 518.39%364K | -149.02%-381K | 993.88%438K | ---87K | ---153K | ---49K |
| -Change in other working capital | 95.45%-1K | 208.89%49K | 54.02%-40K | ---22K | ---45K | ---87K |
| Cash from discontinued investing activities | ||||||
| Operating cash flow | 36.46%-1.07M | -92.32%-1.75M | -35.80%-4.53M | ---1.68M | ---911K | ---3.34M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | 0 | -101.18%-6K | 209.35%573K | -2K | 507K | -524K |
| Net PPE purchase and sale | --0 | ---6K | 265.00%66K | ---2K | --0 | ---40K |
| Net investment purchase and sale | --0 | --0 | 204.75%507K | --0 | --507K | ---484K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | --0 | -101.18%-6K | 209.35%573K | ---2K | --507K | ---524K |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | 0 | -81.03%522K | 522K | 0 | 2.75M | |
| Net preferred stock issuance | --0 | ---- | -81.01%522K | --522K | ---- | --2.75M |
| Proceeds from stock option exercised by employees | --0 | ---- | --0 | --0 | --0 | --3K |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | --0 | --0 | -81.03%522K | --522K | --0 | --2.75M |
| Net cash flow | ||||||
| Beginning cash position | -64.27%2.83M | -44.10%4.65M | -17.59%8.31M | --7.92M | --8.31M | --10.08M |
| Current changes in cash | 7.87%-1.07M | -335.15%-1.76M | -210.21%-3.43M | ---1.16M | ---404K | ---1.11M |
| Effect of exchange rate changes | 93.14%-19K | -394.74%-56K | 65.52%-230K | ---277K | --19K | ---667K |
| End cash Position | -73.09%1.75M | -64.27%2.83M | -44.10%4.65M | --6.49M | --7.92M | --8.31M |
| Free cash flow | 36.53%-1.07M | -92.97%-1.76M | -34.55%-4.54M | ---1.68M | ---911K | ---3.38M |
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg